Needham & Company Reiterates Buy on Intel (INTC) Following 3Q Earnings Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
FIDO Alliance Appoints American Express, Infineon, and VASCO to Board of Directors
October 14, 2015 8:00 AM EDTMOUNTAIN VIEW, CA -- (Marketwired) -- 10/14/15 -- The FIDO (Fast IDentity Online) Alliance (https://www.fidoalliance.org/), an industry consortium launched in 2013 to revolutionize online security with open standards for simpler, stronger authentication, today announced that American... More
FIDO Alliance Opens Worldwide Cooperation & Liaison Program - Welcomes Associations to Partner on FIDO Standards for Universal Strong Authentication
October 13, 2015 8:02 AM EDTMOUNTAIN VIEW, CA -- (Marketwired) -- 10/13/15 -- The FIDO (Fast IDentity Online) Alliance (https://www.fidoalliance.org/), an industry consortium launched in 2013 to revolutionize online security with open standards for simpler, stronger authentication, today introduced the FIDO Cooperation & Liaison Program, inviting associations worldwide to... More
Intec Pharma Announces Topline Results of a Food Effect, Pharmacokinetic Study of AP-CDLD 50/500mg for the Treatment of Parkinson's Disease Symptoms
October 12, 2015 9:38 PM EDTJERUSALEM, ISRAEL -- (Marketwired) -- 10/12/15 -- Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced results of the food effect study of the Phase 3 formulation of its leading product candidate, Accordion Pill Carbidopa/Levodopa, or AP-CDLD. The results demonstrated that plasma concentrations of carbidopa and levodopa were similar, with no statistically significant differences in all PK parameters... More
